Lin-rui Ma
Macau, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Dachengqi Decoction: emerging therapeutic potential in sepsis and target organ injury.
Journal: Frontiers in pharmacology
Published: December 07, 2025
CERS4 predicts positive anti-PD-1 response and promotes immunomodulation through Rhob-mediated suppression of CD8+Tim3+ exhausted T cells in non-small cell lung cancer.
Journal: Pharmacological research
Published: May 25, 2023
Traditional Herbal Medicine: A Potential Therapeutic Approach for Adjuvant Treatment of Non-small Cell Lung Cancer in the Future.
Journal: Integrative cancer therapies
Published: December 26, 2022
Targeting Mutant Kirsten Rat Sarcoma Viral Oncogene Homolog in Non-Small Cell Lung Cancer: Current Difficulties, Integrative Treatments and Future Perspectives.
Journal: Frontiers in pharmacology
Published: February 14, 2022
A method establishment and comparison of in vivo lung cancer model development platforms for evaluation of tumour metabolism and pharmaceutical efficacy.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: July 20, 2021
Metabolomics and integrated network pharmacology analysis reveal Tricin as the active anti-cancer component of Weijing decoction by suppression of PRKCA and sphingolipid signaling.
Journal: Pharmacological research
Published: February 18, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026